The World Health Organization’s pandemic programme plans to ship 100m doses of the Sinovac and Sinopharm Covid-19 shots by the end of next month, mostly to Africa and Asia, in its first delivery of Chinese vaccines, a WHO document shows.
Reuters reports that the Chinese shipments will help the sputtering global Covax vaccine sharing programme which is far behind its pledge to deliver 2bn doses this year following supply problems and export curbs imposed by major producer India.
It could also boost Beijing’s vaccine diplomacy efforts despite concerns over the efficacy of the Chinese shots, which have been turned down or paired with boosters from Western manufacturers by some of the recipient countries.
Of the 100m Chinese vaccines, half will be provided by Sinopharm and half by Sinovac, with deliveries planned for “July to September 2021”, a WHO document dated 29 July says.
About 10 million Sinopharm shots had been shipped by mid-August, a spokesperson for the Global Alliance for Vaccines and Immunization (GAVI), which co-leads COVAX along with the WHO, told Reuters.
Sinopharm, Sinovac and China’s trade ministry did not respond to requests for comment about when the Chinese vaccines would be delivered.
The Chinese vaccines have been allocated to 60 countries, mostly in Africa, which is expected to receive a third of the 100m doses.
However, not all countries want the Chinese vaccines.
South Africa is listed by Covax as one of Africa’s largest recipients of Chinese shots with an allocation of 2.5m Sinovac doses, but a senior health official told Reuters the country was currently unable to accept the vaccines.
“There is not enough information on effectiveness against the Delta variant and there is no data on Sinovac in populations with HIV,” said Nicholas Crisp, a deputy director-general in the health department who is overseeing the vaccine rollout.
“We have not accepted the COVAX Sinovac because it is premature in our evaluation and planning process,” he told Reuters.
Sinovac did not immediately respond to a request for comment about South Africa’s stance.
Nigeria, the main recipient of Chinese shots in Africa under Covax with an allocation of nearly 8m Sinopharm doses, has approved that vaccine but has called it a “potential” option for the country’s inoculation campaign.